Bank of America’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-469,500
| Closed | -$46.6M | – | 7767 |
|
|
2019
Q3 | $46.6M | Buy |
469,500
+50,300
| +12% | +$4.78M | 0.01% | 1177 |
|
|
2019
Q2 | $38.8M | Sell |
419,200
-740,700
| -64% | -$70.3M | 0.01% | 1326 |
|
|
2019
Q1 | $109M | Buy |
1,159,900
+713,400
| +160% | +$62.4M | 0.02% | 704 |
|
|
2018
Q4 | $28.6M | Sell |
446,500
-24,900
| -5% | -$1.84M | 0.01% | 1400 |
|
|
2018
Q3 | $42.2M | Buy |
471,400
+41,100
| +10% | +$3.63M | 0.01% | 1222 |
|
|
2018
Q2 | $34.2M | Buy |
430,300
+108,000
| +34% | +$8.97M | 0.01% | 1370 |
|
|
2018
Q1 | $28.8M | Sell |
322,300
-160,400
| -33% | -$15.4M | ﹤0.01% | 1472 |
|
|
2017
Q4 | $50.4M | Buy |
482,700
+91,700
| +23% | +$10.3M | 0.01% | 1084 |
|
|
2017
Q3 | $57M | Sell |
391,000
-30,000
| -7% | -$4.09M | 0.01% | 1055 |
|
|
2017
Q2 | $54.7M | Sell |
421,000
-264,200
| -39% | -$32.4M | 0.01% | 992 |
|
|
2017
Q1 | $85.3M | Buy |
685,200
+447,100
| +188% | +$53.5M | 0.02% | 759 |
|
|
2016
Q4 | $27.6M | Buy |
238,100
+7,300
| +3% | +$813K | 0.01% | 1416 |
|
|
2016
Q3 | $24.1M | Sell |
230,800
-50,600
| -18% | -$5.48M | 0.01% | 1511 |
|
|
2016
Q2 | $27.8M | Sell |
281,400
-159,900
| -36% | -$16.5M | 0.01% | 1359 |
|
|
2016
Q1 | $44.2M | Buy |
441,300
+50,000
| +13% | +$5.15M | 0.01% | 1003 |
|
|
2015
Q4 | $46.9M | Buy |
391,300
+147,200
| +60% | +$17M | 0.01% | 1035 |
|
|
2015
Q3 | $26.4M | Sell |
244,100
-31,100
| -11% | -$3.86M | 0.01% | 1403 |
|
|
2015
Q2 | $31.9M | Sell |
275,200
-600
| -0.2% | -$68.6K | 0.01% | 1094 |
|
|
2015
Q1 | $31.8M | Sell |
275,800
-177,000
| -39% | -$21.2M | 0.01% | 1060 |
|
|
2014
Q4 | $50.6M | Sell |
452,800
-65,000
| -13% | -$6.86M | 0.02% | 840 |
|
|
2014
Q3 | $49.1M | Sell |
517,800
-216,300
| -29% | -$19.5M | 0.02% | 856 |
|
|
2014
Q2 | $63M | Buy |
734,100
+407,300
| +125% | +$31M | 0.02% | 721 |
|
|
2014
Q1 | $22.8M | Buy |
326,800
+203,600
| +165% | +$16.1M | 0.01% | 1203 |
|
|
2013
Q4 | $10.4M | Sell |
123,200
-16,400
| -12% | -$1.3M | ﹤0.01% | 1827 |
|
|
2013
Q3 | $10.8M | Buy |
139,600
+64,800
| +87% | +$4.54M | ﹤0.01% | 1725 |
|
|
2013
Q2 | $4.38M | Buy |
+74,800
| New | +$4.5M | ﹤0.01% | 2411 |
|
Other funds holding CELG
FP
HCM
PCMC
WCG
Bank of America's CELG Position: Q4 2019 in Review
Bank of America sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 4,074,972 shares — an estimated $405M sold.
Bank of America first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $1.88B in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.
- Bank of America reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
- Bank of America sold 4,074,972 Celgene Corp shares in Q4 2019, an estimated $405M.
- Bank of America first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
- Bank of America's Celgene Corp position peaked at $1.88B in Q3 2017.
- 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.
Based on Bank of America's 13F filing for Q4 2019, filed 14 Feb 2020.